Article
Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation.
Movement disorders : official journal of the Movement Disorder Society - 1 Aug 2006
Isaias Ioannis U, Benti Riccardo, Goldwurm Stefano, Zini Michela, Cilia Roberto, Gerundini Paolo, Di Fonzo Alessio, Bonifati Vincenzo, Pezzoli Gianni, Antonini Angelo
Abstract excerpt
We measured striatal dopamine transporter binding using [(123)I]ioflupane and SPECT in patients with Parkinson's disease associated with the LRRK2 (PARK8) Gly2019Ser gene mutation (LRRK2-PD) and in gene-negative patients with idiopathic Parkinson's disease (IPD) of comparable disease duration and severity. The LRRK2-PD group consisted of a total of 10 patients (3 sporadic) with mean age 62 +/- 14 years, disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
